Nomura Downgrades Pharmacyclics (PCYC) to Neutral; Deal Supports Further M&A (INFI) (RCPT) (ICPT) (INCY) (NBIX) (GEVA) Mar 5, 2015 01:15PM
Pharmacyclics (PCYC) Worth Up to $274/Share in Takeout - Nomura Feb 26, 2015 08:30AM
Nomura Securities Upgrades Pharmacyclics (PCYC) to Buy Feb 19, 2015 06:59AM
Nomura Securities Downgrades Pharmacyclics (PCYC) to Neutral Jan 5, 2015 06:51AM
Pharmacyclics (PCYC) PT Lifted to $175 at Nomura on Strong Q3 Nov 5, 2014 10:04AM


May 15, 2014 08:46AM Buy Incyte Genomics, Inc. (INCY) and Pharmacyclics (PCYC) Into ASCO Meeting
Mar 20, 2014 07:46AM Pharmacyclics (PCYC), Gilead Sciences (GILD) Target Prices Lifted at Nomura; Biogen (BIIB) Trimmed
Feb 21, 2014 07:51AM Pharmacyclics (PCYC) Target Lifted to $166 at Nomura on Solid Q4 Led by Strong Imbruvica Launch
Jan 8, 2014 07:51AM Nomura Securities Starts Pharmacyclics (PCYC) at Buy